TNF and cerebral malaria: Experiments in which IL-10 was administered in mouse models of malaria resulted in a lower production of TNF-α and a lower incidence of experimental cerebral malaria (ECM) (22, 23), leading some to hypothesize that IL-10 counteracts the potentially pathological host proinflammatory response to malaria (14).